Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on February 14th, 2014% Han Cao (A. Kotok)
14 February 2014. Three entrepreneurs starting companies based on science described how they got their businesses off the ground, with ground-breaking science in many cases more important than a large stash of venture capital. San Diego entrepreneurs John Newsam, Irwin Jacobs, and Han Cao told of their start-up business . . . → Read More: Science-Based Enterprises: Great Ideas Beat Venture Capital
By Alan, on February 13th, 2014% Phillip Sharp (A. Kotok)
13 February 2014. Phillip Sharp, professor of molecular biology at MIT and president of American Association for Advancement of Science (AAAS), underscored the tight connection between scientific advancement, entrepreneurship, and economic growth, in the opening plenary session of the AAAS annual conference in Chicago.
Sharp described the way scientific . . . → Read More: AAAS Pres: Science Drives Innovation, Economic Growth
By Alan, on February 13th, 2014% Termes robots (Eliza Grinnell, Harvard University)
13 February 2014. Computer scientists and bio-engineers at Harvard University created a system inspired by termites that controls the work of autonomous robots in complex construction tasks. The team led by computer scientist Radhika Nagpal published its findings in the new issue of the journal Science (paid . . . → Read More: Bio-Inspired Cooperative Robotic Control System Developed
By Alan, on February 13th, 2014% John Noseworthy (A. Kotok)
13 February 2014. Optum Labs, a partnership to increase sharing of solutions and data to improve health care, says seven more organizations from the private, university, and not-for-profit sectors became members of the collaboration. The new participants join current Optum Labs members Optum, a subsidiary of UnitedHealth Group, Mayo . . . → Read More: Health Research Collaborative Adds Seven New Members
By Alan, on February 12th, 2014% (AAAS.org)
12 February 2014. Starting tomorrow, Science & Enterprise will report directly from the American Association for the Advancement of Science (AAAS) annual meeting in Chicago. Of course, I need to get there first, which in today’s climate-changed weather will be something of a challenge.
In the meantime, here’s a video (7 minutes) . . . → Read More: Ticket to Ride
By Alan, on February 12th, 2014% Adeno-associated virus (LBL.gov)
12 February 2014. Voyager Therapeutics, a new start-up in Cambridge, Massachusetts creating gene therapies for disorders of the central nervous system, gained $45 million in first-round financing. Third Rock Ventures, a venture capital company specializing in life science enterprises, provided the funds for the company founded by researchers at University of . . . → Read More: Start-Up Developing Gene Therapies Lands $45M in Early Funds
By Alan, on February 11th, 2014% Photomicrograph of Cryptococcus (CDC.gov)
11 February 2014. Medical researchers at University of Rochester in New York found two drugs treating breast cancer have properties that point to their potential as a treatment for Cryptococcus, a fungus causing meningitis in people with HIV/AIDS. The team led by Rochester’s Damian Krysan, with colleagues from Temple and . . . → Read More: Cancer Drugs Shown With Potential Against HIV-Related Fungus
By Alan, on February 11th, 2014% FRI image for lobar hyperinflation (Fluidda nv)
11 February 2014. A group of companies and universities in Belgium and the U.S. are collaborating on an advanced imaging technology to spot signs of lung transplant rejection earlier in a patient’s recovery. Fluidda nv in Kontich, Belgium is leading the collaboration, with additive manufacturing company . . . → Read More: Belgium-U.S. Consortium Developing Lung Image Technology
By Alan, on February 10th, 2014% High oleic hemp oil (University of York)
10 February 2014. Biologists at University of York in the U.K. developed a new form of hemp plant that produces seeds with oil containing a high volume of oleic acid, a nutritious fatty acid like that found in olive oil. The team led by York’s Ian . . . → Read More: Engineered Hemp Delivers High Volume of Healthy Oleic Acid
By Alan, on February 10th, 2014% Listeria bacteria (CDC.gov)
10 February 2014. Aduro BioTech Inc. in Berkeley, California started treating ist first patients in an intermediate-stage clinical trial of immunotherapies for pancreatic cancer. The trial is expected to enroll 240 patients at 20 sites in the U.S. and Canada, and is still recruiting participants.
Pancreatic cancer is often difficult . . . → Read More: Trial Underway Testing Pancreatic Cancer Immunotherapy
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.